Recombinant Mycoplasma Pneumoniae P1-C

Introduction Mycoplasma pneumonia is part of the atypical pneumonia subtype which is caused by the bacteria M. pneumoniae. Mycoplasma pneumonia affects individuals younger than 40. It makes up 15 - 50% of all pneumonia cases in adults and especially in school-aged children. People at great risk for mycoplasma pneumonia comprise of those living or working in busy areas such as schools and homeless shelters, although many people who contract mycoplasma pneumonia have no identifiable risk factor. P1, P30, and P116 of mycoplasma pneumonia membrane proteins have been recognized as adhensive factors, P1 is considered as a main adhension protein of the organism colonization.

Recombinant Mycoplasma Pneumoniae P1-CDescription The Recombinant Mycoplasma Pneumoniae C-terminal region (P1C) of the P1 protein was expessed in E. coli having an Mw of 65kDa. The protein is fused to a GST-Tag.

This peptide can be used as an antigen in the diagnosis of M. pneumoniae infection.

Source E.Coli

Purification Method The recombinant fusion protein was purified by GSH affinity chromatography technique.

Physical Appearence Streile filtered colorless solution.

Recombinant Mycoplasma Pneumoniae P1-CFormulation Mycoplasma Pneumoniae P1-C is formulated in 1x PBS pH 7.4 and 0.5mM EDTA.

Stability Upon arrival, Store at -20℃.

Please prevent freeze-thaw cycles.

Purity Greater than 95% as determined by 12% PAGE (Coomassie staining).

Application Can be used for lateral follow product, ELISA assay and vaccine development.

Recombinant Mycoplasma Pneumoniae P1-CUsage CHIs products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.